Source: StreetInsider

Press Release: Spiderwort : FDA grants a Breakthrough Device Designation for Spiderwort Spinal Cord Technology

Read full article »

Spiderwort's Competitors | Spiderwort's News | Spiderwort's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Charles M. Cuerrier

CEO Approval Rating

86/100

Spiderwort is a Canada-based biotechnology company that develops and commercializes novel cellulose biomaterials for the treatment of soft tissue replacement.